Of the 32 participants who received tirzepatide, ten participants reported a total of 25 treatment-emergent adverse events
Ideally you should cover up exposed areas, sunscreens act as a second layer of protection
A diagnosis of Psammomatous Melanotic Schwannoma is made using the following tools: Complete physical examination with thorough evaluation of the individuals medical history (including history of Carney complex) Neurological exam of the entire body Radiological studies (CT, MRI scan) of the affected region Nerve conduction studies of the affected nerve Other specific tests may be conducted based on the location of the tumor Tissue biopsy: A tissue biopsy is performed and sent to a laboratory for a pathological examination, who examines the biopsy under a microscope
its relevance to retatrutide specifically is not yet established A history of pancreatitis or significant gastrointestinal disease Gallbladder disease , including a history of gallstones or cholecystitis Diabetes mellitus , particularly if managed with insulin or sulphonylureas, due to hypoglycaemia risk Cardiovascular disease , including arrhythmias or recent cardiac events Renal or hepatic impairment , which may affect tolerability and increase the risk of dehydration-related complications Pregnancy or breastfeeding no safety data exist for retatrutide in these groups Use of oral medicines where absorption may be affected by delayed gastric emptying , such as levothyroxine or combined oral contraceptives Seek urgent medical attention if you experience severe or persistent nausea or vomiting, persistent abdominal pain (which may indicate pancreatitis or gallbladder disease), signs of an allergic reaction (rash, swelling, difficulty breathing), chest pain, palpitations, or signs of dehydration
